"Uncorking" of liposomes by matrix metalloproteinase-9

Nihar R Sarkar1, Theresa Rosendahl, Aaron B Krueger

  • 1Department of Chemistry and Molecular Biology, North Dakota State University, Fargo, North Dakota 58105, USA. sanku.mallik@ndsu.nodak.edu

Chemical Communications (Cambridge, England)
|February 19, 2005
PubMed

Insights

This study introduces a novel triggered release method for liposomes, utilizing the enzyme matrix metalloproteinase-9 (MMP-9). This approach enables precise release of liposomal contents in response to specific biological cues.

Area of Science:

  • Biochemistry
  • Materials Science
  • Drug Delivery

Background:

  • Liposomes are widely used drug delivery vehicles.
  • Controlled release of encapsulated substances is crucial for therapeutic efficacy.
  • Enzyme-responsive systems offer targeted drug release mechanisms.

Purpose of the Study:

  • To develop and describe a triggered release methodology for liposomal contents.
  • To investigate the use of matrix metalloproteinase-9 (MMP-9) as a trigger for liposomal release.

Main Methods:

  • Liposomes were engineered for MMP-9 sensitivity.
  • Enzyme-triggered release assays were performed.
  • Characterization of liposomal integrity and payload release was conducted.

Main Results:

  • Demonstrated successful triggered release of liposomal contents.
  • Confirmed MMP-9's efficacy in cleaving the liposomal structure.
  • Quantified the release kinetics in response to MMP-9.

Conclusions:

  • A novel MMP-9-triggered liposomal release system was successfully developed.
  • This methodology offers a promising strategy for targeted drug delivery.
  • Further research can explore applications in various therapeutic areas.